Prostamax
Also known as: Lys-Glu-Asp-Pro
Overview
A tetrapeptide bioregulator directed at prostate tissue, sold widely with minimal supporting evidence.
Prostamax is classified as a short peptide bioregulator. Its current development status is: preclinical / russian clinical use. The published evidence is thin, largely non-independent, or does not address the uses this compound is marketed for.
The Peptide Institute tracks Prostamax because it is actively sold through research-compound and telehealth channels. Our interest is narrow and specific: what is actually in the vial, whether the label is accurate, and whether the sellers of it can document what they claim. We take no position on whether anyone should use it.
Independent Testing
Independently tested companies that sell Prostamax
Every company below was evaluated with product the Institute purchased anonymously and sent for third-party laboratory analysis. Ranked by Index Score™.
- Companies
- 1
- Samples
- 1
- Updated
- Jun 13, 2026
- 1 Apex Peptides Exceptional Institute
Top Rated Prostamax99.1% average purity across 1 sample
Purity & Testing 99 Transparency 90 Samples 1 91 View company
Research & Studies
Studies library-
Prostamax: dose-ranging efficacy and safety findings
One of the more methodologically careful entries in the Prostamax literature.
-
Prostamax: dose-ranging efficacy and safety findings
One of the more methodologically careful entries in the Prostamax literature.
-
Prostamax in preclinical models: efficacy and translational limits
One of the more methodologically careful entries in the Prostamax literature.
Independent Testing
Testing databaseLaboratory verification of Prostamax products across the companies we index.
Community Discussions
ForumThe Peptide Institute Weekly
Research. Testing. Regulation. No hype.
One email a week: new study summaries, the latest independent lab results, ranking movements, and regulatory developments that matter.
- New research, summarized in plain English
- Independent lab results as they publish
- Score and ranking movements
